Jacques Dumas
Chairman at Nosopharm SAS
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jean-Charles Henri Naouri | M | 75 |
Euris SAS
 Euris SAS Real Estate DevelopmentFinance Euris SA is one of the main investment holding companies in France which derives its revenues from the operations of the retail groups Rallye and Casino & holds a diverse portfolio of other investments. Operating in France, the U.S., Spain, Morrocco and the U.K., it holds significant interests in the distribution, real estate, industrial & financial services and also publishing & communications sectors. | 37 years |
| Dominique Leblanc | M | 72 | 2 years | |
| Virginie Sabine Grin | F | 56 |
Euris SAS
Euris SAS Real Estate DevelopmentFinance Euris SA is one of the main investment holding companies in France which derives its revenues from the operations of the retail groups Rallye and Casino & holds a diverse portfolio of other investments. Operating in France, the U.S., Spain, Morrocco and the U.K., it holds significant interests in the distribution, real estate, industrial & financial services and also publishing & communications sectors. | 30 years |
| Philippe Villain-Guillot | M | - |
Nosopharm SAS
 Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | 15 years |
| Maxime Gualtieri | M | - |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | 15 years |
| Frederic Hammel | M | - |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | - |
| Didier Lévêque | M | 62 |
Euris SAS
Euris SAS Real Estate DevelopmentFinance Euris SA is one of the main investment holding companies in France which derives its revenues from the operations of the retail groups Rallye and Casino & holds a diverse portfolio of other investments. Operating in France, the U.S., Spain, Morrocco and the U.K., it holds significant interests in the distribution, real estate, industrial & financial services and also publishing & communications sectors. | 35 years |
| Odile Muracciole | F | 64 | 8 years | |
| Sandra Dubos | F | - |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | - |
| Laurent Fraisse | M | - |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | - |
| Martin Lauriot Prévost | M | - |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alain Deloz | M | 77 | 12 years | |
| Charles-Henri Filippi | M | 72 |
Euris SAS
Euris SAS Real Estate DevelopmentFinance Euris SA is one of the main investment holding companies in France which derives its revenues from the operations of the retail groups Rallye and Casino & holds a diverse portfolio of other investments. Operating in France, the U.S., Spain, Morrocco and the U.K., it holds significant interests in the distribution, real estate, industrial & financial services and also publishing & communications sectors. | 7 years |
| Pierre Féraud | M | 83 | 5 years | |
| Jean-Marie Grisard | M | 81 |
Euris SAS
Euris SAS Real Estate DevelopmentFinance Euris SA is one of the main investment holding companies in France which derives its revenues from the operations of the retail groups Rallye and Casino & holds a diverse portfolio of other investments. Operating in France, the U.S., Spain, Morrocco and the U.K., it holds significant interests in the distribution, real estate, industrial & financial services and also publishing & communications sectors. | 20 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 15 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jacques Dumas
- Personal Network